# Radiopharm Theranostics Limited (RADX)

> Healthcare · AU · Reports in AUD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RADX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 2.76M | $ -55.05M | $ -22.26M | $ 0 | $ 24.69M |
| 2024 | N/A | N/A | $ -22.75M | $ 0 | $ 53.20M |
| 2023 | N/A | N/A | $ -13.46M | $ 0 | $ 28.12M |
| 2022 | N/A | N/A | N/A | $ 0 | $ 44.38M |
| 2021 | N/A | N/A | N/A | $ 0 | $ 62.96M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 1.53 |
| Current Ratio | 1.16 |

## Other views

- [Metrics](https://sponda.capital/en/RADX.md)
- [Charts](https://sponda.capital/en/RADX/charts.md)
- [Compare](https://sponda.capital/en/RADX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.